Skip to main content

How AI will decrease overdiagnosis and overtreatment of prostate cancer

AI, short for artificial intelligence, is in the headlines increasingly. Medical care is expected to receive the biggest benefits in the field, including prostate cancer.

Active Surveillance Patients International presents a panel talking about AI and how it will be affecting our lives as prostate cancer patients.

8:52 Kirk Wojno, MD
31:14 Bruno Barrey
35:02 Daniel Spratt
54:08 Tim Showalter, MD, MPH
1:05:17 Q & A

If you would like to donate to ASPI please visit us at:

Share this: